IMMUTEP LIMITED - Announcements

2.88%

26.8¢

Market Cap $392.6M

Healthcare Biotechnology

Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company... Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing Lymphocyte Activation Gene (LAG)-3 immunotherapies for cancer and autoimmune diseases. Its lead product candidate, Eftilagimod alpha (efti or IMP321), is a soluble LAG-3Ig fusion protein that is an antigen-presenting cell (APC) agonist designed to capitalize on LAG-3’s ability to drive the adaptive and innate immune systems against cancer. IMP761 is an immunosuppressive agonist antibody to LAG-3, which has the potential to address the root cause of autoimmune diseases by specifically silencing autoimmune memory T cells. Its third product candidate is LAG525, an antagonist (blocking) antibody targeting the LAG-3 molecule on T cells with potential applications in the treatment of cancer. Its fourth product candidate is IMP731 (GSK 781), a depleting (cytotoxic) antibody that is intended to destroy LAG-3 expressing activated T cells involved in autoimmunity.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

IMM	Webcast to discuss IMP761 preclinical results		19/03/19	215.12KB	Share
IMM	IMP761 results presented at ECCO conference	PRICE SENSITIVE	08/03/19	279.67KB	Share
IMM	Immutep receives A$872,351 R&D Tax Incentive	PRICE SENSITIVE	07/03/19	237.13KB	Share
IMM	Immutep doses First Patient in TACTI-002 Phase II Trial	PRICE SENSITIVE	06/03/19	253.22KB	Share
IMM	TACTI-mel data presented at World Immunotherapy Congress	PRICE SENSITIVE	06/03/19	180.88KB	Share
IMM	Immutep to present at Oppenheimer Healthcare Conference		04/03/19	142.15KB	Share
IMM	Half Year Accounts	PRICE SENSITIVE	27/02/19	612.38KB	Share
IMM	Immutep to present at upcoming industry conferences		26/02/19	229.36KB	Share
IMM	Immutep Presentation to Emergence Conference		25/02/19	1.07MB	Share
IMM	Immutep Investor Update		31/01/19	1.13MB	Share
IMM	Appendix 4C - quarterly	PRICE SENSITIVE	24/01/19	207.76KB	Share
IMM	Immutep enters into collaboration with CYTLIMIC	PRICE SENSITIVE	07/01/19	144.89KB	Share
IMM	Change of Director's Interest Notice - Dr Howard		04/01/19	216.53KB	Share
IMM	Change of Director's Interest Notice - Mr Voigt		04/01/19	199.91KB	Share
IMM	Appendix 3B		02/01/19	591.76KB	Share
IMM	Becoming a substantial holder		24/12/18	190.57KB	Share
IMM	Disclosure Under LR 3.10.5A and 7.1A.4(b)		21/12/18	310.93KB	Share
IMM	Cleansing Notice		21/12/18	131.43KB	Share
IMM	Appendix 3B		21/12/18	620.41KB	Share
IMM	Cleansing prospectus for issue of warrants	PRICE SENSITIVE	20/12/18	461.93KB	Share
IMM	Immutep announces US$5.2 million capital raising	PRICE SENSITIVE	19/12/18	282.14KB	Share
IMM	European patent granted for IMP321 & antibody combinations	PRICE SENSITIVE	29/11/18	219.82KB	Share
IMM	Immutep granted European patent for IMP321	PRICE SENSITIVE	28/11/18	223.76KB	Share
IMM	Immutep presents new TACTI-mel data at ICI Europe Summit	PRICE SENSITIVE	27/11/18	242.93KB	Share
IMM	Change of Director's Interest Notice - Dr Howard		26/11/18	273.54KB	Share
IMM	Appendix 3B		21/11/18	590.48KB	Share
IMM	Results of Meeting		16/11/18	247.42KB	Share
IMM	2018 AGM CEO Presentation		16/11/18	975.91KB	Share
IMM	2018 AGM Chairman's Address		16/11/18	213.53KB	Share
IMM	Positive interim TACTI-mel data presented at SITC	PRICE SENSITIVE	12/11/18	161.19KB	Share
IMM	Operational Update	PRICE SENSITIVE	01/11/18	251.12KB	Share
IMM	AusBiotech Invest presentation slides		30/10/18	895.32KB	Share
IMM	Appendix 4C - quarterly	PRICE SENSITIVE	25/10/18	189.44KB	Share
IMM	Data Presentations at Upcoming Industry Conferences		24/10/18	235.22KB	Share
IMM	Annual Report filed on Form 20-F with SEC		22/10/18	580.15KB	Share
IMM	Notice of Annual General Meeting/Proxy Form		11/10/18	1.06MB	Share
IMM	Annual Report to shareholders		11/10/18	940.68KB	Share
IMM	Appendix 4G & Corporate Governance Statement		11/10/18	397.76KB	Share
IMM	Appendix 3B & cleansing notice		04/10/18	320.63KB	Share
IMM	Appendix 3B & cleansing notice		03/10/18	319.38KB	Share
IMM	Change of Director's Interest Notice - Mr Chamberlain		02/10/18	178.42KB	Share
IMM	Change of Director's Interest Notice - Mr Meyers		02/10/18	184.92KB	Share
IMM	Appendix 3B & cleansing notice		02/10/18	602.15KB	Share
IMM	Ceasing to be a substantial holder from AEF		02/10/18	235.15KB	Share
IMM	Immutep to present at SITC 2018		02/10/18	221.26KB	Share
IMM	Appendix 3B & cleansing notice		28/09/18	427.57KB	Share
IMM	Appendix 3B & cleansing notice		27/09/18	637.63KB	Share
IMM	Change in substantial holding from AEF		27/09/18	136.26KB	Share
IMM	Immutep to present at Ladenburg Thalmann conference		26/09/18	221.51KB	Share
IMM	Immutep enters into collaboration with Pfizer & Merck KGaA	PRICE SENSITIVE	24/09/18	233.26KB	Share
IMM	Immutep presentation for BioCentury NewsMakers conference		07/09/18	1.31MB	Share
IMM	Change in substantial holding from AEF		03/09/18	386.57KB	Share
IMM	Progress towards clinical development of IMP761	PRICE SENSITIVE	03/09/18	159.78KB	Share
IMM	Appendix 4E & 2018 Full Year Statutory Accounts	PRICE SENSITIVE	21/08/18	969.17KB	Share
IMM	Immutep receives A$1.9M from French R&D tax cash rebate	PRICE SENSITIVE	21/08/18	228.45KB	Share
IMM	Immutep to present at BioCentury NewsMakers conference		16/08/18	228.55KB	Share
IMM	TACTI-mel Patient Recruitment Complete & Operational Update	PRICE SENSITIVE	07/08/18	249.57KB	Share
IMM	Immutep secures Canadian patent grant for IMP731 antibody	PRICE SENSITIVE	07/08/18	211.91KB	Share
IMM	Immutep receives IND approval from US FDA for IMP321	PRICE SENSITIVE	31/07/18	225.75KB	Share
IMM	Appendix 4C - quarterly	PRICE SENSITIVE	30/07/18	190KB	Share
IMM	Immutep submits IND application with FDA	PRICE SENSITIVE	02/07/18	214.46KB	Share
IMM	Immutep Investor Update		19/06/18	968.82KB	Share
IMM	Mid-point of patient enrolment reached in AIPAC trial	PRICE SENSITIVE	19/06/18	212.37KB	Share
IMM	Immutep Poster Presentations at ASCO		04/06/18	173.53KB	Share
IMM	Webcast slides for TACTI-mel clinical trial data	PRICE SENSITIVE	30/05/18	1.62MB	Share
IMM	New Data from Ongoing TACTI-mel Study	PRICE SENSITIVE	30/05/18	163.67KB	Share
IMM	3rd Annual Advances in Immuno-Oncology Congress Presentation		25/05/18	2MB	Share
IMM	Webcast to discuss interim results from TACTI-mel		17/05/18	274.96KB	Share
IMM	Response to ASX Price Query	PRICE SENSITIVE	15/05/18	262.46KB	Share
IMM	Immutep to present at ASCO		04/05/18	214.06KB	Share
IMM	Appendix 4C - quarterly	PRICE SENSITIVE	23/04/18	189.47KB	Share
IMM	Appendix 3B		13/04/18	575.92KB	Share
IMM	Completion of Share Purchase Plan		13/04/18	264.99KB	Share
IMM	Operational Update	PRICE SENSITIVE	03/04/18	238.1KB	Share
IMM	Cambridge Healthtech Institute's I-O Summit Presentation		23/03/18	135.35KB	Share
IMM	Patient dosing commences in additional TACTI-mel cohort		22/03/18	212.41KB	Share
IMM	Becoming a substantial holder from AEF		19/03/18	227.98KB	Share
IMM	Disclosure Under Listing Rules 3.10.5A and 7.1A.4(b)		14/03/18	209.8KB	Share
IMM	Appendix 3B & Cleansing Notice		14/03/18	730.29KB	Share
IMM	Share Purchase Plan Offer Documents		13/03/18	629.57KB	Share
IMM	Immutep raises A$6.85M through institutional placement	PRICE SENSITIVE	12/03/18	349.38KB	Share
IMM	Immutep enters into collaboration with MSD	PRICE SENSITIVE	12/03/18	277.17KB	Share
IMM	US patent grant for IMP701 antibody	PRICE SENSITIVE	06/03/18	280.96KB	Share
IMM	Immutep receives A$686,704 R&D Tax Incentive	PRICE SENSITIVE	05/03/18	204.27KB	Share
IMM	Half Yearly Report and Accounts	PRICE SENSITIVE	22/02/18	648.97KB	Share
IMM	Outcome of DSMB Safety Review & Extension of TACTI-mel	PRICE SENSITIVE	09/02/18	439.65KB	Share
IMM	Immutep receives USD1M milestone payment from EOC	PRICE SENSITIVE	01/02/18	344.75KB	Share
IMM	Appendix 4C - quarterly	PRICE SENSITIVE	22/01/18	107.14KB	Share
IMM	Change of Director's Interest Notice - Russell Howard		22/12/17	801.58KB	Share
IMM	Investor Update		21/12/17	607.77KB	Share
IMM	Operational Update	PRICE SENSITIVE	12/12/17	532.03KB	Share
IMM	Change of Director's Interest Notice - Mr Voigt		04/12/17	440.7KB	Share
IMM	Change of Director's Interest Notice - Mr Chamberlain		04/12/17	478.96KB	Share
IMM	Appendix 3B		04/12/17	312.85KB	Share
IMM	Prima BioMed company name changed to Immutep		28/11/17	479.86KB	Share
IMM	Final Director's Interest Notice		22/11/17	723.47KB	Share
IMM	Final Director's Interest Notice		22/11/17	720.58KB	Share
IMM	European patent grant for IMP321 in cancer	PRICE SENSITIVE	22/11/17	376.58KB	Share
IMM	Prima changes its name to Immutep Ltd		20/11/17	101.69KB	Share
IMM	Results of Meeting		17/11/17	518.22KB	Share

IMM Webcast to discuss IMP761 preclinical results
19/03/19		215.12KB	Share
IMM IMP761 results presented at ECCO conference
08/03/19	PRICE SENSITIVE	279.67KB	Share
IMM Immutep receives A$872,351 R&D Tax Incentive
07/03/19	PRICE SENSITIVE	237.13KB	Share
IMM Immutep doses First Patient in TACTI-002 Phase II Trial
06/03/19	PRICE SENSITIVE	253.22KB	Share
IMM TACTI-mel data presented at World Immunotherapy Congress
06/03/19	PRICE SENSITIVE	180.88KB	Share
IMM Immutep to present at Oppenheimer Healthcare Conference
04/03/19		142.15KB	Share
IMM Half Year Accounts
27/02/19	PRICE SENSITIVE	612.38KB	Share
IMM Immutep to present at upcoming industry conferences
26/02/19		229.36KB	Share
IMM Immutep Presentation to Emergence Conference
25/02/19		1.07MB	Share
IMM Immutep Investor Update
31/01/19		1.13MB	Share
IMM Appendix 4C - quarterly
24/01/19	PRICE SENSITIVE	207.76KB	Share
IMM Immutep enters into collaboration with CYTLIMIC
07/01/19	PRICE SENSITIVE	144.89KB	Share
IMM Change of Director's Interest Notice - Dr Howard
04/01/19		216.53KB	Share
IMM Change of Director's Interest Notice - Mr Voigt
04/01/19		199.91KB	Share
IMM Appendix 3B
02/01/19		591.76KB	Share
IMM Becoming a substantial holder
24/12/18		190.57KB	Share
IMM Disclosure Under LR 3.10.5A and 7.1A.4(b)
21/12/18		310.93KB	Share
IMM Cleansing Notice
21/12/18		131.43KB	Share
IMM Appendix 3B
21/12/18		620.41KB	Share
IMM Cleansing prospectus for issue of warrants
20/12/18	PRICE SENSITIVE	461.93KB	Share
IMM Immutep announces US$5.2 million capital raising
19/12/18	PRICE SENSITIVE	282.14KB	Share
IMM European patent granted for IMP321 & antibody combinations
29/11/18	PRICE SENSITIVE	219.82KB	Share
IMM Immutep granted European patent for IMP321
28/11/18	PRICE SENSITIVE	223.76KB	Share
IMM Immutep presents new TACTI-mel data at ICI Europe Summit
27/11/18	PRICE SENSITIVE	242.93KB	Share
IMM Change of Director's Interest Notice - Dr Howard
26/11/18		273.54KB	Share
IMM Appendix 3B
21/11/18		590.48KB	Share
IMM Results of Meeting
16/11/18		247.42KB	Share
IMM 2018 AGM CEO Presentation
16/11/18		975.91KB	Share
IMM 2018 AGM Chairman's Address
16/11/18		213.53KB	Share
IMM Positive interim TACTI-mel data presented at SITC
12/11/18	PRICE SENSITIVE	161.19KB	Share
IMM Operational Update
01/11/18	PRICE SENSITIVE	251.12KB	Share
IMM AusBiotech Invest presentation slides
30/10/18		895.32KB	Share
IMM Appendix 4C - quarterly
25/10/18	PRICE SENSITIVE	189.44KB	Share
IMM Data Presentations at Upcoming Industry Conferences
24/10/18		235.22KB	Share
IMM Annual Report filed on Form 20-F with SEC
22/10/18		580.15KB	Share
IMM Notice of Annual General Meeting/Proxy Form
11/10/18		1.06MB	Share
IMM Annual Report to shareholders
11/10/18		940.68KB	Share
IMM Appendix 4G & Corporate Governance Statement
11/10/18		397.76KB	Share
IMM Appendix 3B & cleansing notice
04/10/18		320.63KB	Share
IMM Appendix 3B & cleansing notice
03/10/18		319.38KB	Share
IMM Change of Director's Interest Notice - Mr Chamberlain
02/10/18		178.42KB	Share
IMM Change of Director's Interest Notice - Mr Meyers
02/10/18		184.92KB	Share
IMM Appendix 3B & cleansing notice
02/10/18		602.15KB	Share
IMM Ceasing to be a substantial holder from AEF
02/10/18		235.15KB	Share
IMM Immutep to present at SITC 2018
02/10/18		221.26KB	Share
IMM Appendix 3B & cleansing notice
28/09/18		427.57KB	Share
IMM Appendix 3B & cleansing notice
27/09/18		637.63KB	Share
IMM Change in substantial holding from AEF
27/09/18		136.26KB	Share
IMM Immutep to present at Ladenburg Thalmann conference
26/09/18		221.51KB	Share
IMM Immutep enters into collaboration with Pfizer & Merck KGaA
24/09/18	PRICE SENSITIVE	233.26KB	Share
IMM Immutep presentation for BioCentury NewsMakers conference
07/09/18		1.31MB	Share
IMM Change in substantial holding from AEF
03/09/18		386.57KB	Share
IMM Progress towards clinical development of IMP761
03/09/18	PRICE SENSITIVE	159.78KB	Share
IMM Appendix 4E & 2018 Full Year Statutory Accounts
21/08/18	PRICE SENSITIVE	969.17KB	Share
IMM Immutep receives A$1.9M from French R&D tax cash rebate
21/08/18	PRICE SENSITIVE	228.45KB	Share
IMM Immutep to present at BioCentury NewsMakers conference
16/08/18		228.55KB	Share
IMM TACTI-mel Patient Recruitment Complete & Operational Update
07/08/18	PRICE SENSITIVE	249.57KB	Share
IMM Immutep secures Canadian patent grant for IMP731 antibody
07/08/18	PRICE SENSITIVE	211.91KB	Share
IMM Immutep receives IND approval from US FDA for IMP321
31/07/18	PRICE SENSITIVE	225.75KB	Share
IMM Appendix 4C - quarterly
30/07/18	PRICE SENSITIVE	190KB	Share
IMM Immutep submits IND application with FDA
02/07/18	PRICE SENSITIVE	214.46KB	Share
IMM Immutep Investor Update
19/06/18		968.82KB	Share
IMM Mid-point of patient enrolment reached in AIPAC trial
19/06/18	PRICE SENSITIVE	212.37KB	Share
IMM Immutep Poster Presentations at ASCO
04/06/18		173.53KB	Share
IMM Webcast slides for TACTI-mel clinical trial data
30/05/18	PRICE SENSITIVE	1.62MB	Share
IMM New Data from Ongoing TACTI-mel Study
30/05/18	PRICE SENSITIVE	163.67KB	Share
IMM 3rd Annual Advances in Immuno-Oncology Congress Presentation
25/05/18		2MB	Share
IMM Webcast to discuss interim results from TACTI-mel
17/05/18		274.96KB	Share
IMM Response to ASX Price Query
15/05/18	PRICE SENSITIVE	262.46KB	Share
IMM Immutep to present at ASCO
04/05/18		214.06KB	Share
IMM Appendix 4C - quarterly
23/04/18	PRICE SENSITIVE	189.47KB	Share
IMM Appendix 3B
13/04/18		575.92KB	Share
IMM Completion of Share Purchase Plan
13/04/18		264.99KB	Share
IMM Operational Update
03/04/18	PRICE SENSITIVE	238.1KB	Share
IMM Cambridge Healthtech Institute's I-O Summit Presentation
23/03/18		135.35KB	Share
IMM Patient dosing commences in additional TACTI-mel cohort
22/03/18		212.41KB	Share
IMM Becoming a substantial holder from AEF
19/03/18		227.98KB	Share
IMM Disclosure Under Listing Rules 3.10.5A and 7.1A.4(b)
14/03/18		209.8KB	Share
IMM Appendix 3B & Cleansing Notice
14/03/18		730.29KB	Share
IMM Share Purchase Plan Offer Documents
13/03/18		629.57KB	Share
IMM Immutep raises A$6.85M through institutional placement
12/03/18	PRICE SENSITIVE	349.38KB	Share
IMM Immutep enters into collaboration with MSD
12/03/18	PRICE SENSITIVE	277.17KB	Share
IMM US patent grant for IMP701 antibody
06/03/18	PRICE SENSITIVE	280.96KB	Share
IMM Immutep receives A$686,704 R&D Tax Incentive
05/03/18	PRICE SENSITIVE	204.27KB	Share
IMM Half Yearly Report and Accounts
22/02/18	PRICE SENSITIVE	648.97KB	Share
IMM Outcome of DSMB Safety Review & Extension of TACTI-mel
09/02/18	PRICE SENSITIVE	439.65KB	Share
IMM Immutep receives USD1M milestone payment from EOC
01/02/18	PRICE SENSITIVE	344.75KB	Share
IMM Appendix 4C - quarterly
22/01/18	PRICE SENSITIVE	107.14KB	Share
IMM Change of Director's Interest Notice - Russell Howard
22/12/17		801.58KB	Share
IMM Investor Update
21/12/17		607.77KB	Share
IMM Operational Update
12/12/17	PRICE SENSITIVE	532.03KB	Share
IMM Change of Director's Interest Notice - Mr Voigt
04/12/17		440.7KB	Share
IMM Change of Director's Interest Notice - Mr Chamberlain
04/12/17		478.96KB	Share
IMM Appendix 3B
04/12/17		312.85KB	Share
IMM Prima BioMed company name changed to Immutep
28/11/17		479.86KB	Share
IMM Final Director's Interest Notice
22/11/17		723.47KB	Share
IMM Final Director's Interest Notice
22/11/17		720.58KB	Share
IMM European patent grant for IMP321 in cancer
22/11/17	PRICE SENSITIVE	376.58KB	Share
IMM Prima changes its name to Immutep Ltd
20/11/17		101.69KB	Share
IMM Results of Meeting
17/11/17		518.22KB	Share

REFRESH

First 5 6 7 8 9

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 26.8¢		Change 0.008(2.88%)		Mkt cap ! $392.6M

Open	High	Low	Value	Volume
26.5¢	27.0¢	26.3¢	$37.21K	140.3K

Buyers (Bids)

No.	Vol.	Price($)
18	217828	26.5¢

Sellers (Offers)

Price($)	Vol.	No.
27.0¢	169534	21

View Market Depth

No.	Vol.	Price($)
18	217828	0.265
24	700585	0.260
18	541322	0.255
19	363230	0.250
14	648643	0.245

Price($)	Vol.	No.
0.270	157833	18
0.275	362470	16
0.280	702218	13
0.285	371431	14
0.290	366715	7

Last trade - 10.38am 13/08/2025 (20 minute delay)


Last 26.8¢		Change 0.008 ( 1.06 %)
Open	High	Low	Volume
26.5¢	27.0¢	26.5¢	147438
Last updated 10.52am 13/08/2025 ?

IMM (ASX) Chart

IMMUTEP LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available